Clindamycin hydrochloride

This classification denotes a lincosamide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T20OQ1YN1W. European Medicines Agency schedules Clindamycin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01342MIG. Clindamycin hydrochloride generally arises in the molecular formula C18H33CLN2O5S.CLH. The term 'clindamycin hydrochloride' is a U.S. Pharmacopeial Convention designation. Most nations, for tariff and trade purposes, schedule clindamycin hydrochloride under HS 29419000 and SITC 54139. As of Q4 2014, CLINDAMYCIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Clindamycin hydrochloride bears US NLM identifiers UMLS ID C0282105 and NCI Concept Code C47977. SMILES: CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)CL.CL.